Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Shanghai Junshi Biosciences (1877 HK)
Watchlist
212
Analysis
Health Care
•
China
Shanghai Junshi Biosciences Co., Ltd. operates as a biopharmaceutical company. The Company develops and sells small molecule drugs, antibody drug conjugates, and other products. Shanghai Junshi Biosciences markets its products worldwide.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Quantitative Analysis
•
22 May 2022 11:46
A-H Premium Weekly: Asymchem Lab, Shanghai Junshi, Great Wall Motor
We highlight A-H premium changes of Asymchem Lab, Shanghai Junshi, Great Wall Motor, Shandong Xinhua, Conch Cement, BBMG, and Sinopec Oilfield last...
Ke Yan, CFA, FRM
Follow
251 Views
Share
bearish
•
Thematic (Sector/Industry)
•
22 May 2022 09:05
China Healthcare Weekly (May20)-Lockdown Impact on Macro Economy, Bottom Signal? Rare Disease Policy
The lockdown could make economic sense, which is significant for coming economic crisis;We analyzed the bottom signal of biotech/CXO/medical...
Xinyao (Criss) Wang
Follow
261 Views
Share
bullish
•
Thematic (Sector/Industry)
•
15 May 2022 09:20
China Healthcare Weekly (May13)-New Bioeconomy Plan,Rational Withdrawal from NRDL,Medical Device VBP
The 14th Five-Year Bioeconomy plan indicates a new economic form and a trillion-level market.Medical device will be a better investment if...
Xinyao (Criss) Wang
Follow
260 Views
Share
bearish
•
Thematic (Sector/Industry)
•
11 May 2022 08:55
Re-Examine the Outlook and Investment Strategy for China Biotech and CXO
The investment logic of China biotech has broken due to dilemma of domestic policy and internationalization risk.CXO couldn't sustain high...
Xinyao (Criss) Wang
Follow
248 Views
Share
bullish
•
Thematic (Sector/Industry)
•
08 May 2022 09:03
China Healthcare Weekly (May.6)-FDA’s CRL on Junshi/HCM, Biotech Globalization, Significance of DRGs
The FDA announced its CRL on Hutchmed’s surufatinib and Junshi’s PD-1. It's time to reexamine the logic and prospects of biotech globalization. The...
Xinyao (Criss) Wang
Follow
272 Views
Share
First
Previous
16
17
18
19
20
21
22
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.34.5
x